Unknown

Dataset Information

Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.


ABSTRACT:

Background

Organotypic cultures derived from pancreatic ductal adenocarcinoma (PDAC) termed pancreatic ductal cancer organoids (PDOs) recapitulate the primary cancer and can be derived from primary or metastatic biopsies. Although isolation and culture of patient-derived pancreatic organoids were established several years ago, pros and cons for individualized medicine have not been comprehensively investigated to date.

Methods

We conducted a feasibility study, systematically comparing head-to-head patient-derived xenograft tumor (PDX) and PDX-derived organoids by rigorous immunohistochemical and molecular characterization. Subsequently, a drug testing platform was set up and validated in vivo. Patient-derived organoids were investigated as well.

Results

First,

SUBMITTER: Frappart PO 

PROVIDER: S-EPMC7268941 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature